A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Clinical trial NCT07175493 · RECRUITING

Trial details

NCT number: NCT07175493
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Autoimmune Cytopenia Immune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia Evans Syndrome

Start date: 2025-11-18
Primary completion: 2027-11-18
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.